Powder: -20°C for 3 years | In solvent: -80°C for 2 years
m-PEG7-CH2-OH a PEG-based based PROTAC Linker can be used in the synthesis of PROTACs.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
100 mg | Inquiry | Inquiry | |
500 mg | Inquiry | Inquiry |
Description | m-PEG7-CH2-OH a PEG-based based PROTAC linker can be used in the synthesis of PROTACs. |
In vitro | PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins. |
Molecular Weight | 354.44 |
Formula | C16H34O8 |
CAS No. | 1807512-35-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 2 years
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
m-PEG7-CH2-OH 1807512-35-1 Others m PEG7 CH2 OH m-PEG-7-CH2-OH mPEG7CH2OH inhibitor inhibit